The Nov. 5 Daily Dose incorrectly named the equity partners to remain after a deal closed between Renal Advantage and Liberty Dialysis. The equity sponsors are Bain Capital, KRG Capital Partners and Ignition Partners. The brief also stated incorrectly that the proposed deal to create a holding company had yet to name a future CEO. The CEO will be Mark Caputo.
Corrections and clarifications
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You